RECRUITING

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This protocol pertains specifically to the prospective lung squamous cell carcinoma pre-malignant lesion (PML) cohort that will form a primary study group for the Lung Pre-Cancer Atlas.

Official Title

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy

Quick Facts

Study Start:2019-12-06
Study Completion:2026-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03881098

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. A current or ex-smoker with a \> 20 pack-year history of smoking.
  2. 2. History of non-small cell lung cancer (stage I, II, or IIIA) with\> 10 pack-year history of smoking and no evidence of active disease at least 1 year after definitive treatment.
  3. 3. History of head and neck cancer (stage I, II, III, or IVA) with \> 10 pack-year history of smoking and no evidence of active disease at least 1 year after definitive treatment.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Brandi Kubala
CONTACT
303-724-1657
brandi.kubala@cuanschutz.edu

Principal Investigator

Robert Keith, MD
PRINCIPAL_INVESTIGATOR
University of Colorado, Denver

Study Locations (Sites)

Rocky Mountain Regional VAMC
Aurora, Colorado, 80045
United States
UCHealth - Metro
Aurora, Colorado, 80045
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Robert Keith, MD, PRINCIPAL_INVESTIGATOR, University of Colorado, Denver

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-12-06
Study Completion Date2026-01

Study Record Updates

Study Start Date2019-12-06
Study Completion Date2026-01

Terms related to this study

Keywords Provided by Researchers

  • Bronchoscopy
  • Squamous Cell Carcinoma
  • Pre-Malignant Lesions
  • Smoking
  • Multi-site

Additional Relevant MeSH Terms

  • Lung Cancer